doi:10.1186/s12933-023-01897-2 Chang HY, Chou YY, Tang W, et al
Effects of switching from liraglutide or dulaglutide to subcutaneous semaglutide on glucose metabolism and treatment satisfaction in patients with type 2 diabetes: protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)
*Correspondence: Sameer A
Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacity
If you haven't lost at least 5% of your body weight by week 16, your clinician will reassess and discuss alternative approaches
Sleep quality and stress management influence cortisol and hunger hormones, which can either support or undermine pharmacological treatment